An Immune-Related Long Noncoding RNA Pair as a New Biomarker to Predict the Prognosis of Patients in Breast Cancer

An Immune-Related Long Noncoding RNA Pair as a New Biomarker to Predict the Prognosis of Patients in Breast Cancer

Background: Immune-related long non-coding RNAs (irlncRNAs) might remodel the tumor immune microenvironment by changing the inherent properties of tumor cells and the expression of immune genes, which have been used to predict the efficacy of immunotherapy and the prognosis of various tumors. Howeve...

Full description

Bibliographic Details
Main Authors:	Hanwen Jiang, Jingxian Sun, Fucong Liu, Xincai Wu, Zhaohui Wen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-06-01
Series:	Frontiers in Genetics
Subjects:	breast cancer immune-related lncRNA pair MIR4435-2HG biomarker TCGA
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2022.895200/full

Similar Items

Long non-coding RNA MIR4435-2HG: a key molecule in progression of cancer and non-cancerous disorders
by: Majid Ghasemian, et al.
Published: (2022-06-01)

LncRNA MIR4435-2HG predicts poor prognosis in patients with colorectal cancer
by: Wen Ouyang, et al.
Published: (2019-04-01)

LncRNA MIR4435-2HG is downregulated in osteoarthritis and regulates chondrocyte cell proliferation and apoptosis
by: Yu Xiao, et al.
Published: (2019-08-01)

The lncRNA MIR4435-2HG is upregulated in hepatocellular carcinoma and promotes cancer cell proliferation by upregulating miRNA-487a
by: Qinglei Kong, et al.
Published: (2019-04-01)

MIR4435-2HG Is a Potential Pan-Cancer Biomarker for Diagnosis and Prognosis
by: Chenming Zhong, et al.
Published: (2022-06-01)

Exploration of Identification and Prognostic Analysis of a Novel Immune-Related lncRNA Pair Signature and Immune Landscape in Esophageal Adenocarcinoma: A New Method Based on “Continuous Learning” Model
by: Yang Yu, et al.
Published: (2023-06-01)

A novel signature to predict thyroid cancer prognosis and immune landscape using immune-related LncRNA pairs
by: Bo Song, et al.
Published: (2022-08-01)

Knockdown of MIR4435-2HG Suppresses the Proliferation, Migration and Invasion of Cervical Cancer Cells via Regulating the miR-128-3p/MSI2 Axis in vitro
by: Wang R, et al.
Published: (2020-09-01)

Role of ferroptosis and ferroptosis-related long non'coding RNA in breast cancer
by: Shasha Xiang, et al.
Published: (2024-03-01)

The role of lncRNA just proximal to XIST (JPX) in human disease phenotypes and RNA methylation: The novel biomarker and therapeutic target potential
by: Yirui Kuang, et al.
Published: (2022-11-01)

Investigating diagnostic potential of long non-coding RNAs in head and neck squamous cell carcinoma using TCGA database and clinical specimens
by: Ting Lan, et al.
Published: (2024-03-01)

A hypoxia‐related lncRNA model for prediction of head and neck squamous cell carcinoma prognosis
by: Junwei Xiang, et al.
Published: (2023-02-01)

Biological Roles and Pathogenic Mechanisms of LncRNA MIR4435-2HG in Cancer: A Comprehensive Review
by: Zhou Chen, et al.
Published: (2023-11-01)

Identification of a vascular invasion-related signature based on lncRNA pairs for predicting prognosis in hepatocellular carcinoma
by: Nan Zhao, et al.
Published: (2024-01-01)

LncRNA MIR4435-2HG triggers ovarian cancer progression by regulating miR-128-3p/CKD14 axis
by: Lijuan Zhu, et al.
Published: (2020-05-01)

Construction of an lncRNA model for prognostic prediction of bladder cancer
by: Changlong Shi, et al.
Published: (2022-12-01)

Exploration of the Immune-Related Long Noncoding RNA Prognostic Signature and Inflammatory Microenvironment for Cervical Cancer
by: Hui Yao, et al.
Published: (2022-05-01)

Comprehensive Analysis of a Competing Endogenous RNA Network Identifies Seven-lncRNA Signature as a Prognostic Biomarker for Melanoma
by: Nian Liu, et al.
Published: (2019-10-01)

Long non-coding RNA, LINC01614 as a potential biomarker for prognostic prediction in breast cancer
by: Yaozong Wang, et al.
Published: (2019-11-01)

A Novel Glycolysis-Related Long Noncoding RNA Signature for Predicting Overall Survival in Gastric Cancer
by: Jianmin Zeng, et al.
Published: (2022-11-01)

A novel immune-related lncRNA pair signature for prognostic prediction and immune response evaluation in gastric cancer: a bioinformatics and biological validation study
by: Jun Wang, et al.
Published: (2022-02-01)

Identification of a three-long noncoding RNA prognostic model involved competitive endogenous RNA in kidney renal clear cell carcinoma
by: Di Zhang, et al.
Published: (2020-07-01)

The Clinical Utility of lncRNAs and Their Application as Molecular Biomarkers in Breast Cancer
by: Cristian Arriaga-Canon, et al.
Published: (2023-04-01)

Glycolysis-associated lncRNAs identify a subgroup of cancer patients with poor prognoses and a high-infiltration immune microenvironment
by: Kuo-Hao Ho, et al.
Published: (2021-02-01)

Identification and validation of an epigenetically regulated long noncoding RNA model for breast cancer metabolism and prognosis
by: Yu Song, et al.
Published: (2022-05-01)

Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma
by: Hui He, et al.
Published: (2020-08-01)

Comprehensive analysis of five long noncoding RNAs expression as competing endogenous RNAs in regulating hepatoma carcinoma
by: Xin Lou, et al.
Published: (2019-09-01)

MIR155HG is a prognostic biomarker and associated with immune infiltration and immune checkpoint molecules expression in multiple cancers
by: Lirong Peng, et al.
Published: (2019-12-01)

Comprehensive analysis of the MIR4435-2HG/miR-1-3p/MMP9/miR-29-3p/DUXAP8 ceRNA network axis in hepatocellular carcinoma
by: Li Zhang, et al.
Published: (2021-10-01)

Pan-cancer systematic identification of lncRNAs associated with cancer prognosis
by: Matthew Ung, et al.
Published: (2020-03-01)

Genome Instability-Associated Long Non-Coding RNAs Reveal Biomarkers for Glioma Immunotherapy and Prognosis
by: Xinzhuang Wang, et al.
Published: (2022-04-01)

Novel risk model based on angiogenesis-related lncRNAs for prognosis prediction of hepatocellular carcinoma
by: Shicheng Xie, et al.
Published: (2023-08-01)

Screening potential lncRNA biomarkers for breast cancer and colorectal cancer combining random walk and logistic matrix factorization
by: Shijun Li, et al.
Published: (2023-01-01)

Long noncoding RNA MIR31HG abrogates the availability of tumor suppressor microRNA-361 for the growth of osteosarcoma
by: Sun Y, et al.
Published: (2019-08-01)

Long Non-coding RNA MIR4435-2HG Promotes Colorectal Cancer Proliferation and Metastasis Through miR-206/YAP1 Axis
by: Xinhua Dong, et al.
Published: (2020-02-01)

LncmiRHG-MIR100HG: A new budding star in cancer
by: Yingnan Wu, et al.
Published: (2022-09-01)

Immune-related long non-coding RNA signature identified prognosis and immunotherapeutic efficiency in bladder cancer (BLCA)
by: Rui Cao, et al.
Published: (2020-06-01)

Integrated analysis of immune-related long noncoding RNAs as diagnostic biomarkers in psoriasis
by: Feixiang Fan, et al.
Published: (2021-03-01)

Prediction of Recurrence in Cervical Cancer Using a Nine-lncRNA Signature
by: Yu Mao, et al.
Published: (2019-04-01)

Development and Validation of an Mesenchymal-Related Long Non-Coding RNA Prognostic Model in Glioma
by: Kebing Huang, et al.
Published: (2021-09-01)